Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 19, 2019 - Allergan and Amgen announced the launch of Mvasi (bevacizumab-awwb), a biosimilar to Genentech’s Avastin (bevacizumab).
Download PDF
Return to publications
